Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition

Eggink, F.A.; Gool, I.C. van; Leary, A.; Pollock, P.M.; Crosbie, E.J.; Mileshkin, L.; ... ; Bosse, T. (2017)

Article / Letter to editor

• Checkpoint inhibition
• endometrial cancer
• high-risk
• molecular classification
• tumor-infiltrating lymphocytes

• All authors: Eggink, F.A.; Gool, I.C. van; Leary, A.; Pollock, P.M.; Crosbie, E.J.; Mileshkin, L.; Jordanova, E.S.; Adam, J.; Freeman-Mills, L.; Church, D.N.; Creutzberg, C.L.; Bruyn, M. de; Nijman, H.W.; Bosse, T.
• Date: 2017-12-31
• Journal: OncoImmunology
• Volume: 6
• Issue: 2
• DOI: doi:10.1080/2162402X.2016.1264565